New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Novavax, Inc. (NVAX) vs Tyra Biosciences, Inc. (TYRA)
- Novavax, Inc. NVAX 7.74 +0.13%
- Tyra Biosciences, Inc. TYRA 20.08 +1.77%
Novavax, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Novavax, Inc. and Tyra Biosciences, Inc. are of similar size ($1.4B and $1.3B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −18.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Novavax, Inc. leads on 7 and Tyra Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | NVAX | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.01% | 0.00% | 70.18% |
| Operating margin | (21.23%) | 0.00% | 0.00% |
| Net margin | (18.64%) | 0.00% | 0.00% |
| Free cash flow margin | (59.09%) | 0.00% | 0.00% |
| Return on equity | 41.08% | (34.89%) | (51.58%) |
| Return on assets | (7.42%) | (32.99%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack